Pro-competitive policies matter for public health, for security and for strategic autonomy

Pharma reform should provide for more timely patient access in Europe

Medicines for Europe outlines trade policy recommendations to strengthen access to medicines and the competitiveness of EU manufacturing

Markus Sieger takes the helm as President ad interim at Medicines for Europe

Council agreement on review of EU pharmaceutical legislation

Medicines for Europe calls for balanced safeguards on access to medicines in EU Water Resilience Strategy

Medicines for Europe Executive Letter to EU 27 Prime Ministers

European Parliament report urges for reassessment of Urban Wastewater Treatment Directive’s impact on medicines

Europe must act now to protect patients and medicines supply

Medicines for Europe Letter on the Implementation of the Bolar Provision in Ukraine